Saturday, 10 October 2026
Flexible mid-life MBS assessment, Childhood obesity definition shift, Iran-based doctors blocked from exam
- 01
Federal review proposes single flexible mid-life MBS assessment
A Federal Government review has proposed replacing several disease-specific MBS health assessments with a single, flexible mid-life assessment using time-tiered items. The change would cover current assessments for menopause and perimenopause, heart health, and patients at risk of chronic disease and type 2 diabetes. The review said a holistic approach could reduce duplicated assessments, patient confusion and administrative complexity, while MBS claims data from 2018–19 to 2022–23 showed only modest patient and provider engagement with existing services. RACGP President Dr Michael Wright supported simplifying the items but said the college would examine the report and the Government’s response before implementation.
via RACGP newsGP
- 02
New definition lowers estimated childhood obesity prevalence
Clinical obesity affected 2.1–4.9% of children and adolescents under a new definition, compared with 7–10.8% classified as obese using BMI criteria. The global study included 786,557 participants, including Australians, and defined clinical obesity by excess body fat accompanied by related health problems or limitations in daily activities. Lead author Dr Danielle Longmore said the distinction could affect assessment and treatment decisions, including weight-loss medications and dietary recommendations. Australian GP experts argued that the lower prevalence estimate should support more individualised assessment rather than less intervention for young people with pre-clinical obesity. The study also found clinical obesity rose throughout adulthood, exceeded BMI-defined obesity from age 55–64 years and peaked at 52% among adults aged 65–74 years.
via RACGP newsGP
- 03
US sanctions block Iran-based doctors from key Australian medical exam
A US Treasury directive now prevents Pearson Professional Assessments from scheduling or delivering the Australian Medical Council multiple-choice examination to doctors living in Iran. The examination is an early requirement for many international medical graduates seeking Australian working rights, and one affected doctor had her Istanbul appointment cancelled after months of preparation and travel arrangements. Pearson is the sole provider, leaving affected candidates unable to reschedule, while the AMC advises those who can to provide evidence of residency outside Iran. A petition with 1100 signatories has called for alternative examination arrangements and protection from lost eligibility or costs; the AMC had not responded by the article’s deadline.
- 04
US launches expanded vaccine injury surveillance and research plan
The US Department of Health and Human Services has launched a plan to strengthen the identification, documentation, investigation and response to health problems reported after vaccination. The initiatives include a National Institutes of Health clinic in Bethesda to investigate potential causes, reimbursement for doctors who report suspected adverse events, updates to make the Vaccine Adverse Event Reporting System more accessible, and mandatory capture of vaccine-related adverse events in electronic health records. HHS said the measures aimed to improve patient outcomes and produce better evidence about potential vaccine-related injuries. Vaccine experts Paul Offit and Kawsar Talaat questioned whether the plan would improve scientific understanding, warning that it could instead increase confusion and further weaken vaccine confidence. The policy comes amid declining US immunisation rates and increasing cases of vaccine-preventable diseases including measles.
via BioPharma Dive · also covered by Healthcare Dive
- 05
Two methohexital injection lots recalled over cellulose particulates
Par Health has voluntarily recalled two lots of Brevital Sodium 500 mg/vial CIV (methohexital sodium for injection, USP) after cellulose particulate matter was identified. The nationwide recall applies at the hospital level. The FDA MedWatch notice was issued on 8 October 2026. The source provides limited detail beyond the affected presentation and reason for recall.
via FDA MedWatch
- 06
Early influenza rise adds to winter pressure in England
Influenza activity in England has risen unusually early, with health officials warning of “ominous” signs of winter pressure building in hospitals. Hospital test positivity reached 6.5% in the week ending 4 October, up from 5% the previous week. The comparable figure was about 1–3% at this point in each of the previous four years. UK Health Security Agency surveillance showed that flu remained at very low levels but had been rising since August, suggesting a potentially early influenza season.
via BMJ
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.